Inhibition of Boschniakia rossica Boschnaloside on Epithelial-Mesenchymal Transition of Hepatoma SMMC-7721 Cells
Affiliation:

1.Yanbian University Hospital;2.Yanbian University Medical College

  • Article
  • | |
  • Metrics
  • |
  • Reference [38]
  • | | | |
  • Comments
    Abstract:

    Objective To investigate the inhibitory effect of Boschniakia rossica boschnaloside (BRBN) on epithelial-mesenchymal transition (EMT), invasion and migration of human hepatoma SMMC-7721 cells. Methods Transforming growth factor β1 (TGFβ1) was used to induce EMT model of SMMC-7721 cells. The cells were divided into the control group, model group and BRBN group. The cell migration was detected with wound healing test, the cell invasion was observed by transwell chamber assay, and the expressions of E-cadherin, N-cadherin, vimentin, Slug, Twist1, ZEB1 and signal transducers and activators of transcription 3 (STAT3) were determined with the western blot method. Results TGFβ1 resulted in the spindle-shaped changes in SMMC-7721 cells, down-regulated the expression of E-cadherin, and up-regulated the expression of N-cadherin and vimentin, suggesting that SMMC-7721 cells have obtained the mesenchymal phenotype. Compared with the model group, the expression of E-cadherin was significantly increased, expressions of N-cadherin and vimentin were reduced, expressions of Slug, Twist1, ZEB1 as well as STAT3 phosphorylation were also down-regulated in SMMC-7721 cells of BRBN group. Conclusions BRBN could inhibit the invasion and migration of human hepatoma SMMC-7721 cells, possibly by reversing EMT through STAT3 pathway.

    Reference
    BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: a Cancer Journal for Clinicians, 2024. doi: 10.3322/caac.21834. Epub ahead of print. PMID: 38572751.
    胡志强,游伟程,潘凯枫,等. 中、美两国癌症流行特征分析——《2023美国癌症统计报告》解读[J]. 科技导报, 2023, 41(18): 18-28.
    HU Z Q, YOU W C, PAN K F, et al. Epidemiological characteristics of cancers in China and America: Interpretation of the report of American cancer statistics, 2023[J]. Science Technology Review, 2023, 41(18): 18-28.
    周昌明,王泽洲,郑莹. 2023年美国癌症数据解读及对中国癌症防治的启示[J]. 中国癌症杂志, 2023, 33(2): 117-125.
    ZHOU C M, WANG Z Z, ZHENG Y. Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China[J]. China Oncology, 2023, 33(2): 117-125.
    QI J, LI M, WANG L, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data[J]. Lancet Public Health. 2023, 8(12):e943-e955.
    陈春苗,张国哲,刘平平,等. 小檗碱通过TGF-β/Smad通路抑制TGF-β1诱导的人肝癌HepG2细胞上皮间质转化的研究[J]. 中国药理学通报, 2020, 36(2):261-267.
    CHEN C M, ZHANG G Z, LIU P P, et al. Berberine inhibits TGF-β1-induced epithelial-mesenchymal transition in human liver cancer HepG2 cells via TGF-β/Smad pathway[J]. Chinese Pharmacological Bulletin, 2020, 36(2):261-267.
    KACHROO P, LEE M H, ZHANG L, et al. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer[J]. Journal of Experimental ClinicalScancerSResearch, 2013, 32, 97.
    SRIVASTAVA A, SHARMA H, CHOWDHURY S, et al. Transforming growth factor-β mediated regulation of epigenome is required for epithelial to mesenchymal transition associated features in liver cancer cells[J]. Heliyon, 2023, 9(4):e14665.
    张航,王辉,杨树东. 草苁蓉的本草考证及药理研究[J]. 长春中医药大学学报, 2016, 32(1): 40-42.
    ZHANG H, WANG H, YANG S D. Herbalogical study and pharmacological effect of Boschniakia rossica[J]. Journal of Changchun University of Chinese Medicine, 2016, 32(1): 40-42.
    陈庆红,张睿,冯秀春,等. 长白山区草苁蓉研究现状与濒危机理[J]. 现代农业科技, 2015, (14): 80-81.
    CHEN Q H, ZHANG R, FENG X C, et al. Research status and endangered mechanism of orobanche coerulescens in Changbai mountain district[J]. Modern Agricultural Science and Technology, 2015, (14): 80-81.
    崔香丹,郑峰,朱洁波,等. 草苁蓉环烯醚萜苷对肝癌细胞凋亡及Bax和Bcl-2蛋白表达的影响[J]. 食品与生物技术学报,2019, 38(12):137-141.
    CUI X D, ZHENG F, ZHU J B, et al. Effect of iridoid glycosides from Boschniakia rossica on apoptosis and expression of Bax and Bcl-2 in liver cancer cells[J]. Journal of Food Science and Biotechnology, 2019, 38(12):137-141.
    郑峰. 草苁蓉环烯醚萜苷对肝癌细胞株及大鼠肝癌抑制作用的实验研究[D]. 延吉:延边大学,2017.
    ZHENG F. Experimental study of the inhibitory effect of iridoids from Boschniakia rossica on liver cancer cell lines and rat liver cancer[D]. Yanji: Yanbian University, 2017.
    朱洁波,董学花,崔香丹,等. 草苁蓉环烯醚萜苷对SK-Hep1细胞EMT的抑制作用及其机制[J]. 广东医学, 2019, 40(22):3103-3107.
    ZHU J B, DONG X H, CUI X D, et al. Inhibitory effect of iridoid glucosides from Boschniakia rossicaon SK-Hep1 cell EMT and its mechanism[J]. Guangdong Medical Journal, 2019, 40(22): 3103-3109.
    LIN L C, LEE L C, HUANG C, et al. Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1[J]. Phytomedicine, 2019, 62:152946.
    杨雪晶,杨辉萍,张天雷. 草苁蓉抗衰老作用的网络药理学研究[J]. 哈尔滨商业大学学报(自然科学版),2024, 40 (2): 131-138.S
    YANG X J, YANG H P, ZHANG T L. Network pharmacological study on anti-aging effect of Boschniakia rossica[J]. Journal of Harbin University of Commerce ( Natural Sciences Edition),2024, 40 (2): 131-138.S
    YIN Z Z, KIM H S, KIM Y H, et al. Iridoid compounds from Boschniakia rossica[J]. Archives of Pharmacal Research, 1999, 22:78-80.
    董学花,延光海,朱洁波,等. 草苁蓉环烯醚萜苷联合5-氟尿嘧啶对人肝癌HepG2、SK-Hep1细胞上皮间质转化的抑制效果研究[J]. 中草药,2020, 51(17):4498-4505.
    DONG X H, YAN G H, ZHU J B, et al. Inhibitory effects of iridoid glycosides from Boschniakia rossica on combined with 5-fluorouracil on human hepatoma HepG2 and SK-Hep1 cells epithelial-mesenchymal transition[J]. Chinese Traditional and Herbal Drugs, 2020, 51(17):4498-4505.
    刘茂林,王晓堂,宋晓娜,等. Gli2调控Hedgehog通路活化对Tca8113细胞增殖?转移和上皮间充质转化的影响[ J]. 中国比较医学杂志,2024, 34(3): 1-9.
    LIU M L, WANG X T, SONG X N, et al. Gli2 regulates the activation of Hedgehog pathway in proliferation, metastasis, and epithelial mesenchymal transformation of Tca8113 cells[J]. Chinese Journal of Comparative Medicine, 2024, 34(3):1-9.
    黄青昕. 人参皂苷辛酸酯Rh2-O通过调控c-jun/COX2/PGE2通路抑制肝癌侵袭转移的机制研究[D]. 南昌:南昌大学,2023.
    HUANG Q X. Mechanism of ginsenoside octanoate Rh2-O inhibiting liver cancer invasion and metastasis by regulating the c-jun/COX2 /PGE2 pathway[D]. Nanchang: Nanchang University, 2023.
    贾茗博. 氯化两面针碱对胶质瘤细胞上皮-间质转化的抑制作用及机制研究[D]. 长春:吉林大学,2020.
    JIA M B. The inhibitory effect of nitidine chloride on epithelial to mesenchymal transition in glioma cells and mechanism[D]. Changchun: Jilin University, 2020.
    SRIVASTAVA A, SHARMA H, KHANNA S, et al. Interleukin-6 induced proliferation is attenuated by transforming growth factor-β-induced signaling in human hepatocellular carcinoma cells[J]. Frontiers in Oncology, 2022, 11:811941.
    SENGEZ B, CARR BI, ALOTAIBI H. EMT and Inflammation: Crossroads in HCC[J]. Journal of GastrointestinalSCancer, 2023, 54(1):204-212.
    LI Y L, ZHANG M M, WU L W, et al. DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD[J]. Journal of Biomedical Science, 2022, 29(1):34.
    SADRKHANLOO M, ENTEZARI M, OROUEI S, et al. STAT3-EMTSaxis in tumors: Modulation of cancer metastasis, stemness and therapy response[J]. Pharmacological Research, 2022, 182:106311
    亓丁,李红梅,梁铭阁,等. 中药活性成分对宫颈癌上皮间充质转化干预作用的研究进展[J]. 上海中医药大学学报,2023, 37(.4):102-108.
    QI D, LI H M, LIANG M G, et al. Research progress on intervention of active components of traditional Chinese medicine on epithelial?mesenchymal transition of cervical cancer[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2023, 37(4):102-108
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:227
  • PDF: 0
  • HTML: 0
  • Cited by: 0
History
  • Received:May 11,2024
  • Revised:May 17,2024
  • Adopted:August 02,2024
Article QR Code